“…In the meantime, from the perspective of clinical practice, the notion that NAFLD is a powerful trigger and amplifier of adverse CVD outcomes can justify targeting NAFLD in the attempt to reduce the risk of incident CVD (as schematically summarized in Figure 3) [2][3][4][5]66,91,[144][145][146][147][148].…”